aluates Reports

$ 0.0

Automative

Global Antirheumatics Pharmaceutical Market Insights, Forecast to 2030

Published Date: December 2024

Report Code: QYRE-Auto-25J5883

Global Antirheumatics Pharmaceutical Market Insights and Forecast to 2028

BUY CHAPTERS

Global Antirheumatics Pharmaceutical Market Insights, Forecast to 2030

Code: QYRE-Auto-25J5883

Report

December 2024

Pages:113

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

AbbVie

Amgen Inc

Pfizer Inc

Roche Holding AG

Novartis International AG

Johnson & Johnson

Bristol–Myers Squibb

Merck

UCB

Eli Lilly and Company

Antirheumatics Pharmaceutical Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Antirheumatics Pharmaceutical Market

Antirheumatics Pharmaceutical refers to drugs that can treat rheumatism, such as non-steroidal anti-inflammatory drugs, steroidal anti-inflammatory drugs, etc.

Market Analysis and Insights: Global Antirheumatics Pharmaceutical Market

The global Antirheumatics Pharmaceutical market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Covers:

This report presents an overview of global market for Antirheumatics Pharmaceutical market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Antirheumatics Pharmaceutical, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Antirheumatics Pharmaceutical, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Antirheumatics Pharmaceutical revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Antirheumatics Pharmaceutical market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Antirheumatics Pharmaceutical revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Antirheumatics Pharmaceutical Market Report

Report Metric	Details
Report Name	Antirheumatics Pharmaceutical Market
CAGR	5%
Segment by Type	Non-Steroidal Anti-Inflammatory Drugs Steroidal Anti-Inflammatory Drugs Slow Acting Drug Immunological Preparation
Segment by Application	Pharmaceutical Industry Hospital and Clinic Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	AbbVie, Amgen, Pfizer, Roche Holding AG, Novartis International AG, Johnson & Johnson, Bristol-Myers Squibb, Merck, UCB S.A., Eli Lilly and Company
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Antirheumatics Pharmaceutical in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Antirheumatics Pharmaceutical companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Antirheumatics Pharmaceutical revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

Who are the main players in the Antirheumatics Pharmaceutical Market report?

Ans: The main players in the Antirheumatics Pharmaceutical Market are AbbVie, Amgen, Pfizer, Roche Holding AG, Novartis International AG, Johnson & Johnson, Bristol-Myers Squibb, Merck, UCB S.A., Eli Lilly and Company

What are the Application segmentation covered in the Antirheumatics Pharmaceutical Market report?

Ans: The Applications covered in the Antirheumatics Pharmaceutical Market report are Pharmaceutical Industry, Hospital and Clinic, Other

What are the Type segmentation covered in the Antirheumatics Pharmaceutical Market report?

Ans: The Types covered in the Antirheumatics Pharmaceutical Market report are Non-Steroidal Anti-Inflammatory Drugs, Steroidal Anti-Inflammatory Drugs, Slow Acting Drug, Immunological Preparation

Recommended Reports

Autoimmune Diseases

Neurological Disorders

Inflammatory & Rheumatic

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Antirheumatics Pharmaceutical Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Non-Steroidal Anti-Inflammatory Drugs

1.2.3 Steroidal Anti-Inflammatory Drugs

1.2.4 Slow Acting Drug

1.2.5 Immunological Preparation

1.3 Market by Application

1.3.1 Global Antirheumatics Pharmaceutical Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Pharmaceutical Industry

1.3.3 Hospital and Clinic

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Antirheumatics Pharmaceutical Market Perspective (2019-2030)

2.2 Global Antirheumatics Pharmaceutical Growth Trends by Region

2.2.1 Antirheumatics Pharmaceutical Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Antirheumatics Pharmaceutical Historic Market Size by Region (2019-2024)

2.2.3 Antirheumatics Pharmaceutical Forecasted Market Size by Region (2025-2030)

2.3 Antirheumatics Pharmaceutical Market Dynamics

2.3.1 Antirheumatics Pharmaceutical Industry Trends

2.3.2 Antirheumatics Pharmaceutical Market Drivers

2.3.3 Antirheumatics Pharmaceutical Market Challenges

2.3.4 Antirheumatics Pharmaceutical Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Antirheumatics Pharmaceutical by Players

3.1.1 Global Antirheumatics Pharmaceutical Revenue by Players (2019-2024)

3.1.2 Global Antirheumatics Pharmaceutical Revenue Market Share by Players (2019-2024)

3.2 Global Antirheumatics Pharmaceutical Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Antirheumatics Pharmaceutical, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global Antirheumatics Pharmaceutical Market Concentration Ratio

3.4.1 Global Antirheumatics Pharmaceutical Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Antirheumatics Pharmaceutical Revenue in 2023

3.5 Global Key Players of Antirheumatics Pharmaceutical Head office and Area Served

3.6 Global Key Players of Antirheumatics Pharmaceutical, Product and Application

3.7 Global Key Players of Antirheumatics Pharmaceutical, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Antirheumatics Pharmaceutical Breakdown Data by Type

4.1 Global Antirheumatics Pharmaceutical Historic Market Size by Type (2019-2024)

4.2 Global Antirheumatics Pharmaceutical Forecasted Market Size by Type (2025-2030)

5 Antirheumatics Pharmaceutical Breakdown Data by Application

5.1 Global Antirheumatics Pharmaceutical Historic Market Size by Application (2019-2024)

5.2 Global Antirheumatics Pharmaceutical Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Antirheumatics Pharmaceutical Market Size (2019-2030)

6.2 North America Antirheumatics Pharmaceutical Market Size by Type

6.2.1 North America Antirheumatics Pharmaceutical Market Size by Type (2019-2024)

6.2.2 North America Antirheumatics Pharmaceutical Market Size by Type (2025-2030)

6.2.3 North America Antirheumatics Pharmaceutical Market Share by Type (2019-2030)

6.3 North America Antirheumatics Pharmaceutical Market Size by Application

6.3.1 North America Antirheumatics Pharmaceutical Market Size by Application (2019-2024)

6.3.2 North America Antirheumatics Pharmaceutical Market Size by Application (2025-2030)

6.3.3 North America Antirheumatics Pharmaceutical Market Share by Application (2019-2030)

6.4 North America Antirheumatics Pharmaceutical Market Size by Country

6.4.1 North America Antirheumatics Pharmaceutical Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America Antirheumatics Pharmaceutical Market Size by Country (2019-2024)

6.4.3 North America Antirheumatics Pharmaceutical Market Size by Country (2025-2030)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Antirheumatics Pharmaceutical Market Size (2019-2030)

7.2 Europe Antirheumatics Pharmaceutical Market Size by Type

7.2.1 Europe Antirheumatics Pharmaceutical Market Size by Type (2019-2024)

7.2.2 Europe Antirheumatics Pharmaceutical Market Size by Type (2025-2030)

7.2.3 Europe Antirheumatics Pharmaceutical Market Share by Type (2019-2030)

7.3 Europe Antirheumatics Pharmaceutical Market Size by Application

7.3.1 Europe Antirheumatics Pharmaceutical Market Size by Application (2019-2024)

7.3.2 Europe Antirheumatics Pharmaceutical Market Size by Application (2025-2030)

7.3.3 Europe Antirheumatics Pharmaceutical Market Share by Application (2019-2030)

7.4 Europe Antirheumatics Pharmaceutical Market Size by Country

7.4.1 Europe Antirheumatics Pharmaceutical Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe Antirheumatics Pharmaceutical Market Size by Country (2019-2024)

7.4.3 Europe Antirheumatics Pharmaceutical Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Antirheumatics Pharmaceutical Market Size (2019-2030)

8.2 China Antirheumatics Pharmaceutical Market Size by Type

8.2.1 China Antirheumatics Pharmaceutical Market Size by Type (2019-2024)

8.2.2 China Antirheumatics Pharmaceutical Market Size by Type (2025-2030)

8.2.3 China Antirheumatics Pharmaceutical Market Share by Type (2019-2030)

8.3 China Antirheumatics Pharmaceutical Market Size by Application

8.3.1 China Antirheumatics Pharmaceutical Market Size by Application (2019-2024)

8.3.2 China Antirheumatics Pharmaceutical Market Size by Application (2025-2030)

8.3.3 China Antirheumatics Pharmaceutical Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Antirheumatics Pharmaceutical Market Size (2019-2030)

9.2 Asia Antirheumatics Pharmaceutical Market Size by Type

9.2.1 Asia Antirheumatics Pharmaceutical Market Size by Type (2019-2024)

9.2.2 Asia Antirheumatics Pharmaceutical Market Size by Type (2025-2030)

9.2.3 Asia Antirheumatics Pharmaceutical Market Share by Type (2019-2030)

9.3 Asia Antirheumatics Pharmaceutical Market Size by Application

9.3.1 Asia Antirheumatics Pharmaceutical Market Size by Application (2019-2024)

9.3.2 Asia Antirheumatics Pharmaceutical Market Size by Application (2025-2030)

9.3.3 Asia Antirheumatics Pharmaceutical Market Share by Application (2019-2030)

9.4 Asia Antirheumatics Pharmaceutical Market Size by Region

9.4.1 Asia Antirheumatics Pharmaceutical Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia Antirheumatics Pharmaceutical Market Size by Region (2019-2024)

9.4.3 Asia Antirheumatics Pharmaceutical Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Antirheumatics Pharmaceutical Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America Antirheumatics Pharmaceutical Market Size by Type

10.2.1 Middle East, Africa, and Latin America Antirheumatics Pharmaceutical Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America Antirheumatics Pharmaceutical Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America Antirheumatics Pharmaceutical Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America Antirheumatics Pharmaceutical Market Size by Application

10.3.1 Middle East, Africa, and Latin America Antirheumatics Pharmaceutical Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America Antirheumatics Pharmaceutical Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America Antirheumatics Pharmaceutical Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America Antirheumatics Pharmaceutical Market Size by Country

10.4.1 Middle East, Africa, and Latin America Antirheumatics Pharmaceutical Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America Antirheumatics Pharmaceutical Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America Antirheumatics Pharmaceutical Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 AbbVie

11.1.1 AbbVie Company Details

11.1.2 AbbVie Business Overview

11.1.3 AbbVie Antirheumatics Pharmaceutical Introduction

11.1.4 AbbVie Revenue in Antirheumatics Pharmaceutical Business (2019-2024)

11.1.5 AbbVie Recent Developments

11.2 Amgen

11.2.1 Amgen Company Details

11.2.2 Amgen Business Overview

11.2.3 Amgen Antirheumatics Pharmaceutical Introduction

11.2.4 Amgen Revenue in Antirheumatics Pharmaceutical Business (2019-2024)

11.2.5 Amgen Recent Developments

11.3 Pfizer

11.3.1 Pfizer Company Details

11.3.2 Pfizer Business Overview

11.3.3 Pfizer Antirheumatics Pharmaceutical Introduction

11.3.4 Pfizer Revenue in Antirheumatics Pharmaceutical Business (2019-2024)

11.3.5 Pfizer Recent Developments

11.4 Roche Holding AG

11.4.1 Roche Holding AG Company Details

11.4.2 Roche Holding AG Business Overview

11.4.3 Roche Holding AG Antirheumatics Pharmaceutical Introduction

11.4.4 Roche Holding AG Revenue in Antirheumatics Pharmaceutical Business (2019-2024)

11.4.5 Roche Holding AG Recent Developments

11.5 Novartis International AG

11.5.1 Novartis International AG Company Details

11.5.2 Novartis International AG Business Overview

11.5.3 Novartis International AG Antirheumatics Pharmaceutical Introduction

11.5.4 Novartis International AG Revenue in Antirheumatics Pharmaceutical Business (2019-2024)

11.5.5 Novartis International AG Recent Developments

11.6 Johnson & Johnson

11.6.1 Johnson & Johnson Company Details

11.6.2 Johnson & Johnson Business Overview

11.6.3 Johnson & Johnson Antirheumatics Pharmaceutical Introduction

11.6.4 Johnson & Johnson Revenue in Antirheumatics Pharmaceutical Business (2019-2024)

11.6.5 Johnson & Johnson Recent Developments

11.7 Bristol-Myers Squibb

11.7.1 Bristol-Myers Squibb Company Details

11.7.2 Bristol-Myers Squibb Business Overview

11.7.3 Bristol-Myers Squibb Antirheumatics Pharmaceutical Introduction

11.7.4 Bristol-Myers Squibb Revenue in Antirheumatics Pharmaceutical Business (2019-2024)

11.7.5 Bristol-Myers Squibb Recent Developments

11.8 Merck

11.8.1 Merck Company Details

11.8.2 Merck Business Overview

11.8.3 Merck Antirheumatics Pharmaceutical Introduction

11.8.4 Merck Revenue in Antirheumatics Pharmaceutical Business (2019-2024)

11.8.5 Merck Recent Developments

11.9 UCB S.A.

11.9.1 UCB S.A. Company Details

11.9.2 UCB S.A. Business Overview

11.9.3 UCB S.A. Antirheumatics Pharmaceutical Introduction

11.9.4 UCB S.A. Revenue in Antirheumatics Pharmaceutical Business (2019-2024)

11.9.5 UCB S.A. Recent Developments

11.10 Eli Lilly and Company

11.10.1 Eli Lilly and Company Company Details

11.10.2 Eli Lilly and Company Business Overview

11.10.3 Eli Lilly and Company Antirheumatics Pharmaceutical Introduction

11.10.4 Eli Lilly and Company Revenue in Antirheumatics Pharmaceutical Business (2019-2024)

11.10.5 Eli Lilly and Company Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

AbbVie

Amgen Inc

Pfizer Inc

Roche Holding AG

Novartis International AG

Johnson & Johnson

Bristol–Myers Squibb

Merck

UCB

Eli Lilly and Company

List of Tables

Table 1. Global Antirheumatics Pharmaceutical Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of Non-Steroidal Anti-Inflammatory Drugs

Table 3. Key Players of Steroidal Anti-Inflammatory Drugs

Table 4. Key Players of Slow Acting Drug

Table 5. Key Players of Immunological Preparation

Table 6. Global Antirheumatics Pharmaceutical Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 7. Global Antirheumatics Pharmaceutical Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Antirheumatics Pharmaceutical Market Size by Region (2019-2024) & (US$ Million)

Table 9. Global Antirheumatics Pharmaceutical Market Share by Region (2019-2024)

Table 10. Global Antirheumatics Pharmaceutical Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 11. Global Antirheumatics Pharmaceutical Market Share by Region (2025-2030)

Table 12. Antirheumatics Pharmaceutical Market Trends

Table 13. Antirheumatics Pharmaceutical Market Drivers

Table 14. Antirheumatics Pharmaceutical Market Challenges

Table 15. Antirheumatics Pharmaceutical Market Restraints

Table 16. Global Antirheumatics Pharmaceutical Revenue by Players (2019-2024) & (US$ Million)

Table 17. Global Antirheumatics Pharmaceutical Revenue Share by Players (2019-2024)

Table 18. Global Top Antirheumatics Pharmaceutical by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antirheumatics Pharmaceutical as of 2023)

Table 19. Global Antirheumatics Pharmaceutical Industry Ranking 2022 VS 2023 VS 2024

Table 20. Global 5 Largest Players Market Share by Antirheumatics Pharmaceutical Revenue (CR5 and HHI) & (2019-2024)

Table 21. Global Key Players of Antirheumatics Pharmaceutical, Headquarters and Area Served

Table 22. Global Key Players of Antirheumatics Pharmaceutical, Product and Application

Table 23. Global Key Players of Antirheumatics Pharmaceutical, Product and Application

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Antirheumatics Pharmaceutical Market Size by Type (2019-2024) & (US$ Million)

Table 26. Global Antirheumatics Pharmaceutical Revenue Market Share by Type (2019-2024)

Table 27. Global Antirheumatics Pharmaceutical Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 28. Global Antirheumatics Pharmaceutical Revenue Market Share by Type (2025-2030)

Table 29. Global Antirheumatics Pharmaceutical Market Size by Application (2019-2024) & (US$ Million)

Table 30. Global Antirheumatics Pharmaceutical Revenue Share by Application (2019-2024)

Table 31. Global Antirheumatics Pharmaceutical Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 32. Global Antirheumatics Pharmaceutical Revenue Share by Application (2025-2030)

Table 33. North America Antirheumatics Pharmaceutical Market Size by Type (2019-2024) & (US$ Million)

Table 34. North America Antirheumatics Pharmaceutical Market Size by Type (2025-2030) & (US$ Million)

Table 35. North America Antirheumatics Pharmaceutical Market Size by Application (2019-2024) & (US$ Million)

Table 36. North America Antirheumatics Pharmaceutical Market Size by Application (2025-2030) & (US$ Million)

Table 37. North America Antirheumatics Pharmaceutical Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 38. North America Antirheumatics Pharmaceutical Market Size by Country (2019-2024) & (US$ Million)

Table 39. North America Antirheumatics Pharmaceutical Market Size by Country (2025-2030) & (US$ Million)

Table 40. Europe Antirheumatics Pharmaceutical Market Size by Type (2019-2024) & (US$ Million)

Table 41. Europe Antirheumatics Pharmaceutical Market Size by Type (2025-2030) & (US$ Million)

Table 42. Europe Antirheumatics Pharmaceutical Market Size by Application (2019-2024) & (US$ Million)

Table 43. Europe Antirheumatics Pharmaceutical Market Size by Application (2025-2030) & (US$ Million)

Table 44. Europe Antirheumatics Pharmaceutical Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Europe Antirheumatics Pharmaceutical Market Size by Country (2019-2024) & (US$ Million)

Table 46. Europe Antirheumatics Pharmaceutical Market Size by Country (2025-2030) & (US$ Million)

Table 47. China Antirheumatics Pharmaceutical Market Size by Type (2019-2024) & (US$ Million)

Table 48. China Antirheumatics Pharmaceutical Market Size by Type (2025-2030) & (US$ Million)

Table 49. China Antirheumatics Pharmaceutical Market Size by Application (2019-2024) & (US$ Million)

Table 50. China Antirheumatics Pharmaceutical Market Size by Application (2025-2030) & (US$ Million)

Table 51. Asia Antirheumatics Pharmaceutical Market Size by Type (2019-2024) & (US$ Million)

Table 52. Asia Antirheumatics Pharmaceutical Market Size by Type (2025-2030) & (US$ Million)

Table 53. Asia Antirheumatics Pharmaceutical Market Size by Application (2019-2024) & (US$ Million)

Table 54. Asia Antirheumatics Pharmaceutical Market Size by Application (2025-2030) & (US$ Million)

Table 55. Asia Antirheumatics Pharmaceutical Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 56. Asia Antirheumatics Pharmaceutical Market Size by Region (2019-2024) & (US$ Million)

Table 57. Asia Antirheumatics Pharmaceutical Market Size by Region (2025-2030) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Antirheumatics Pharmaceutical Market Size by Type (2019-2024) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Antirheumatics Pharmaceutical Market Size by Type (2025-2030) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Antirheumatics Pharmaceutical Market Size by Application (2019-2024) & (US$ Million)

Table 61. Middle East, Africa, and Latin America Antirheumatics Pharmaceutical Market Size by Application (2025-2030) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Antirheumatics Pharmaceutical Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 63. Middle East, Africa, and Latin America Antirheumatics Pharmaceutical Market Size by Country (2019-2024) & (US$ Million)

Table 64. Middle East, Africa, and Latin America Antirheumatics Pharmaceutical Market Size by Country (2025-2030) & (US$ Million)

Table 65. AbbVie Company Details

Table 66. AbbVie Business Overview

Table 67. AbbVie Antirheumatics Pharmaceutical Product

Table 68. AbbVie Revenue in Antirheumatics Pharmaceutical Business (2019-2024) & (US$ Million)

Table 69. AbbVie Recent Developments

Table 70. Amgen Company Details

Table 71. Amgen Business Overview

Table 72. Amgen Antirheumatics Pharmaceutical Product

Table 73. Amgen Revenue in Antirheumatics Pharmaceutical Business (2019-2024) & (US$ Million)

Table 74. Amgen Recent Developments

Table 75. Pfizer Company Details

Table 76. Pfizer Business Overview

Table 77. Pfizer Antirheumatics Pharmaceutical Product

Table 78. Pfizer Revenue in Antirheumatics Pharmaceutical Business (2019-2024) & (US$ Million)

Table 79. Pfizer Recent Developments

Table 80. Roche Holding AG Company Details

Table 81. Roche Holding AG Business Overview

Table 82. Roche Holding AG Antirheumatics Pharmaceutical Product

Table 83. Roche Holding AG Revenue in Antirheumatics Pharmaceutical Business (2019-2024) & (US$ Million)

Table 84. Roche Holding AG Recent Developments

Table 85. Novartis International AG Company Details

Table 86. Novartis International AG Business Overview

Table 87. Novartis International AG Antirheumatics Pharmaceutical Product

Table 88. Novartis International AG Revenue in Antirheumatics Pharmaceutical Business (2019-2024) & (US$ Million)

Table 89. Novartis International AG Recent Developments

Table 90. Johnson & Johnson Company Details

Table 91. Johnson & Johnson Business Overview

Table 92. Johnson & Johnson Antirheumatics Pharmaceutical Product

Table 93. Johnson & Johnson Revenue in Antirheumatics Pharmaceutical Business (2019-2024) & (US$ Million)

Table 94. Johnson & Johnson Recent Developments

Table 95. Bristol-Myers Squibb Company Details

Table 96. Bristol-Myers Squibb Business Overview

Table 97. Bristol-Myers Squibb Antirheumatics Pharmaceutical Product

Table 98. Bristol-Myers Squibb Revenue in Antirheumatics Pharmaceutical Business (2019-2024) & (US$ Million)

Table 99. Bristol-Myers Squibb Recent Developments

Table 100. Merck Company Details

Table 101. Merck Business Overview

Table 102. Merck Antirheumatics Pharmaceutical Product

Table 103. Merck Revenue in Antirheumatics Pharmaceutical Business (2019-2024) & (US$ Million)

Table 104. Merck Recent Developments

Table 105. UCB S.A. Company Details

Table 106. UCB S.A. Business Overview

Table 107. UCB S.A. Antirheumatics Pharmaceutical Product

Table 108. UCB S.A. Revenue in Antirheumatics Pharmaceutical Business (2019-2024) & (US$ Million)

Table 109. UCB S.A. Recent Developments

Table 110. Eli Lilly and Company Company Details

Table 111. Eli Lilly and Company Business Overview

Table 112. Eli Lilly and Company Antirheumatics Pharmaceutical Product

Table 113. Eli Lilly and Company Revenue in Antirheumatics Pharmaceutical Business (2019-2024) & (US$ Million)

Table 114. Eli Lilly and Company Recent Developments

Table 115. Research Programs/Design for This Report

Table 116. Key Data Information from Secondary Sources

Table 117. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Antirheumatics Pharmaceutical Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Antirheumatics Pharmaceutical Market Share by Type: 2023 VS 2030

Figure 3. Non-Steroidal Anti-Inflammatory Drugs Features

Figure 4. Steroidal Anti-Inflammatory Drugs Features

Figure 5. Slow Acting Drug Features

Figure 6. Immunological Preparation Features

Figure 7. Global Antirheumatics Pharmaceutical Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 8. Global Antirheumatics Pharmaceutical Market Share by Application: 2023 VS 2030

Figure 9. Pharmaceutical Industry Case Studies

Figure 10. Hospital and Clinic Case Studies

Figure 11. Other Case Studies

Figure 12. Antirheumatics Pharmaceutical Report Years Considered

Figure 13. Global Antirheumatics Pharmaceutical Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 14. Global Antirheumatics Pharmaceutical Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global Antirheumatics Pharmaceutical Market Share by Region: 2023 VS 2030

Figure 16. Global Antirheumatics Pharmaceutical Market Share by Players in 2023

Figure 17. Global Top Antirheumatics Pharmaceutical Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antirheumatics Pharmaceutical as of 2023)

Figure 18. The Top 10 and 5 Players Market Share by Antirheumatics Pharmaceutical Revenue in 2023

Figure 19. North America Antirheumatics Pharmaceutical Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. North America Antirheumatics Pharmaceutical Market Share by Type (2019-2030)

Figure 21. North America Antirheumatics Pharmaceutical Market Share by Application (2019-2030)

Figure 22. North America Antirheumatics Pharmaceutical Market Share by Country (2019-2030)

Figure 23. United States Antirheumatics Pharmaceutical Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Canada Antirheumatics Pharmaceutical Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe Antirheumatics Pharmaceutical Market Size YoY (2019-2030) & (US$ Million)

Figure 26. Europe Antirheumatics Pharmaceutical Market Share by Type (2019-2030)

Figure 27. Europe Antirheumatics Pharmaceutical Market Share by Application (2019-2030)

Figure 28. Europe Antirheumatics Pharmaceutical Market Share by Country (2019-2030)

Figure 29. Germany Antirheumatics Pharmaceutical Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. France Antirheumatics Pharmaceutical Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. U.K. Antirheumatics Pharmaceutical Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Italy Antirheumatics Pharmaceutical Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Russia Antirheumatics Pharmaceutical Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Nordic Countries Antirheumatics Pharmaceutical Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. China Antirheumatics Pharmaceutical Market Size YoY (2019-2030) & (US$ Million)

Figure 36. China Antirheumatics Pharmaceutical Market Share by Type (2019-2030)

Figure 37. China Antirheumatics Pharmaceutical Market Share by Application (2019-2030)

Figure 38. Asia Antirheumatics Pharmaceutical Market Size YoY (2019-2030) & (US$ Million)

Figure 39. Asia Antirheumatics Pharmaceutical Market Share by Type (2019-2030)

Figure 40. Asia Antirheumatics Pharmaceutical Market Share by Application (2019-2030)

Figure 41. Asia Antirheumatics Pharmaceutical Market Share by Region (2019-2030)

Figure 42. Japan Antirheumatics Pharmaceutical Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. South Korea Antirheumatics Pharmaceutical Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. China Taiwan Antirheumatics Pharmaceutical Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Southeast Asia Antirheumatics Pharmaceutical Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. India Antirheumatics Pharmaceutical Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Australia Antirheumatics Pharmaceutical Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Middle East, Africa, and Latin America Antirheumatics Pharmaceutical Market Size YoY (2019-2030) & (US$ Million)

Figure 49. Middle East, Africa, and Latin America Antirheumatics Pharmaceutical Market Share by Type (2019-2030)

Figure 50. Middle East, Africa, and Latin America Antirheumatics Pharmaceutical Market Share by Application (2019-2030)

Figure 51. Middle East, Africa, and Latin America Antirheumatics Pharmaceutical Market Share by Country (2019-2030)

Figure 52. Brazil Antirheumatics Pharmaceutical Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 53. Mexico Antirheumatics Pharmaceutical Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. Turkey Antirheumatics Pharmaceutical Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. Saudi Arabia Antirheumatics Pharmaceutical Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. Israel Antirheumatics Pharmaceutical Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 57. GCC Countries Antirheumatics Pharmaceutical Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 58. AbbVie Revenue Growth Rate in Antirheumatics Pharmaceutical Business (2019-2024)

Figure 59. Amgen Revenue Growth Rate in Antirheumatics Pharmaceutical Business (2019-2024)

Figure 60. Pfizer Revenue Growth Rate in Antirheumatics Pharmaceutical Business (2019-2024)

Figure 61. Roche Holding AG Revenue Growth Rate in Antirheumatics Pharmaceutical Business (2019-2024)

Figure 62. Novartis International AG Revenue Growth Rate in Antirheumatics Pharmaceutical Business (2019-2024)

Figure 63. Johnson & Johnson Revenue Growth Rate in Antirheumatics Pharmaceutical Business (2019-2024)

Figure 64. Bristol-Myers Squibb Revenue Growth Rate in Antirheumatics Pharmaceutical Business (2019-2024)

Figure 65. Merck Revenue Growth Rate in Antirheumatics Pharmaceutical Business (2019-2024)

Figure 66. UCB S.A. Revenue Growth Rate in Antirheumatics Pharmaceutical Business (2019-2024)

Figure 67. Eli Lilly and Company Revenue Growth Rate in Antirheumatics Pharmaceutical Business (2019-2024)

Figure 68. Bottom-up and Top-down Approaches for This Report

Figure 69. Data Triangulation

Figure 70. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Antiinflammatory Drugs Market Insights Forecast to 2030

Global Anti Rheumatic Drugs Market Research Report 2024

Global Rheumatoid Arthritis RA Medications Market Research Report 2025

Rheumatology Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Rheumatology Arthritis Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Rheumatic Disorders Drug Market Insights Forecast to 2030

Global Non Steroidal Anti Inflammatory Drugs NSAIDs Market Insights Forecast to 2030

Rheumatology Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Rheumatoid Arthritis Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Rheumatoid Arthritis RA Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Rheumatic Disorders Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Nonsteroidal Antiinflammatory Drugs Market Research Report 2025

Non steroidal Anti inflammatory Drugs NSAID Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Rheumatoid Arthritis and Lupus Treatments Market Research Report 2024

Anti inflammatory Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Scleroderma Therapeutics Market Insights Forecast to 2030

Orthopedics Nonsteroidal Anti Inflammatory Drugs NSAIDs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Rhematoid Arthritis Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Anti inflammatory Therapeutics Market Size Manufacturers Supply Chain Sales Channel and Clients 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions